Phreesia Future Growth
Future criteria checks 1/6
Phreesia is forecast to grow earnings and revenue by 72% and 11.9% per annum respectively. EPS is expected to grow by 73.2% per annum. Return on equity is forecast to be -13.9% in 3 years.
Key information
72.0%
Earnings growth rate
73.2%
EPS growth rate
| Healthcare Services earnings growth | 29.7% |
| Revenue growth rate | 11.9% |
| Future return on equity | -13.9% |
| Analyst coverage | Good |
| Last updated | 18 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 1/31/2027 | 545 | -8 | 77 | 86 | 8 |
| 1/31/2026 | 481 | -39 | 37 | 57 | 15 |
| 1/31/2025 | 419 | -68 | 2 | 28 | 15 |
| 7/31/2024 | 390 | -100 | -25 | 1 | N/A |
| 4/30/2024 | 374 | -119 | -44 | -19 | N/A |
| 1/31/2024 | 356 | -137 | -57 | -32 | N/A |
| 10/31/2023 | 338 | -144 | -69 | -45 | N/A |
| 7/31/2023 | 319 | -152 | -85 | -60 | N/A |
| 4/30/2023 | 301 | -162 | -95 | -70 | N/A |
| 1/31/2023 | 281 | -176 | -116 | -90 | N/A |
| 10/31/2022 | 262 | -185 | -138 | -112 | N/A |
| 7/31/2022 | 245 | -181 | -150 | -116 | N/A |
| 4/30/2022 | 228 | -158 | -134 | -103 | N/A |
| 1/31/2022 | 213 | -118 | -106 | -75 | N/A |
| 10/31/2021 | 197 | -80 | -65 | -33 | N/A |
| 7/31/2021 | 180 | -50 | -30 | -9 | N/A |
| 4/30/2021 | 164 | -32 | -27 | -4 | N/A |
| 1/31/2021 | 149 | -27 | -16 | 3 | N/A |
| 10/31/2020 | 140 | -23 | -14 | 0 | N/A |
| 7/31/2020 | 134 | -19 | -16 | -2 | N/A |
| 4/30/2020 | 130 | -83 | -12 | 1 | N/A |
| 1/31/2020 | 125 | -91 | -11 | 1 | N/A |
| 10/31/2019 | 118 | -102 | -16 | -4 | N/A |
| 7/31/2019 | 110 | -113 | -11 | 0 | N/A |
| 4/30/2019 | 104 | -54 | -10 | 1 | N/A |
| 1/31/2019 | 100 | -45 | -12 | -2 | N/A |
| 1/31/2018 | 80 | -38 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 19P is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 19P is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 19P is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 19P's revenue (11.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 19P's revenue (11.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 19P is forecast to be unprofitable in 3 years.